Patents by Inventor Stefanie HAUCK

Stefanie HAUCK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11965560
    Abstract: A bearing assembly includes a bearing unit configured to support a rotating component relative to a stationary component and having a first stationary bearing ring configured to be connected to the stationary component in a rotationally fixed manner by a bearing carrier and a second rotatable bearing ring configured to be connected to the rotating component. The bearing carrier includes at least one electrical conductor configured to make electrical contact with the bearing unit and to make electrical contact with the stationary component or to be electrically connected to the stationary component when the bearing carrier is mounted to the stationary component.
    Type: Grant
    Filed: May 17, 2022
    Date of Patent: April 23, 2024
    Assignee: AKTIEBOLAGET SKF
    Inventors: Juergen Barthelme, Helmut Hauck, Stefanie Seufert, Hubert Herbst
  • Patent number: 11530273
    Abstract: The present invention relates to improved anti-CD73 antibodies which, in comparison to prior art anti-CD73 antibodies bind to a membrane-bound form of CD73 protein having cancer-promoting role and inhibit its enzymatic activity, while essentially not inhibiting a soluble form of CD73 protein involved in cardioprotection. The present invention further relates to methods of generation of such specific anti-CD73 antibodies and uses thereof including uses as medicaments and in methods for treatment, amelioration, prophylaxis and diagnostics of cancer.
    Type: Grant
    Filed: May 23, 2018
    Date of Patent: December 20, 2022
    Assignee: Helmholtz Zentrum München—Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
    Inventors: Reinhard Zeidler, Bettina Von Neubeck, Regina Feederle, Stefanie Hauck
  • Publication number: 20200148781
    Abstract: The present invention relates to improved anti-CD73 antibodies which, in comparison to prior art anti-CD73 antibodies bind to a membrane-bound form of CD73 protein having cancer-promoting role and inhibit its enzymatic activity, while essentially not inhibiting a soluble form of CD73 protein involved in cardioprotection. The present invention further relates to methods of generation of such specific anti-CD73 antibodies and uses thereof including uses as medicaments and in methods for treatment, amelioration, prophylaxis and diagnostics of cancer.
    Type: Application
    Filed: May 23, 2018
    Publication date: May 14, 2020
    Inventors: Reinhard ZEIDLER, Bettina VON NEUBECK, Regina FEEDERLE, Stefanie HAUCK